During the 36th episode of “The Weekly Bioanalysis”, Dom and John touch on something they really haven't yet throughout the course of our podcast - the impact of trends within the drug development industry on consumer costs. There is a very clear course most drugs take throughout their process, but minor changes in industry trends can affect the final outcomes of those steps - and ultimately the final costs to consumers.

"The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every week, KCAS will bring you another 45-60 minutes of friendly banter between our two finest Senior Scientific Advisors as they chat over coffee and brief themselves on what they've learned about the Bioanalytical world the past week.

The Weekly Bioanalysis is brought to you by KCAS. KCAS is a progressive growing contract research organization of well over 100 talented and dedicated individuals committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the Pharmaceutical, Biopharmaceutical, Animal Health and Medical Device industries.